Myocardial Gene Therapy
Global Perfusion Versus Regional Administration Examined
Published in Gene Therapy Weekly, May 18th, 2000
"Global perfusion (GP) and intramyocardial (IM) vector administration represent alternative strategies for cardiac gene therapy," said Leonard Y. Lee and colleagues from the New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, in a second presentation to the 49th Annual Scientific Session of the American College of Cardiology, held in Anaheim, California. "While IM delivery has been shown to provide high local transgene concentrations, GP delivery may be an ideal method of gene transfer when global treatment is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2000-05-18)
More Articles from Gene Therapy Weekly
- Severe Combined Immunodeficiency
Gene Therapy Frees Two Children From Sterile 'Bubbles' - Congestive Heart Failure
Study Suggests New Pathway to Preserve Heart Function After Attack - Head and Neck Cancer
Attenuated Virus Studied as Cancer Treatment in Phase I Trial - Hypercholesterolemia
Long-Term Reversal Achieved with Gene Transfer + CD154 Blockade - Tetrahydrobiopterin Deficiency
Reconstitution of a Metabolic Pathway Corrects Disorder - Tuberculosis
Ringing Endorsement for New TB Drug Target - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
